tradingkey.logo

Labcorp Holdings Inc

LH
查看詳細走勢圖
260.700USD
-3.480-1.32%
交易中 美東報價延遲15分鐘
21.64B總市值
25.43本益比TTM

Labcorp Holdings Inc

260.700
-3.480-1.32%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.32%

5天

+0.89%

1月

-2.32%

6月

-0.16%

今年開始到現在

+13.68%

1年

+12.37%

查看詳細走勢圖

TradingKey Labcorp Holdings Inc股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Labcorp Holdings Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名17/78位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價299.75。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Labcorp Holdings Inc評分

相關信息

行業排名
17 / 78
全市場排名
87 / 4592
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 21 分析師
買入
評級
299.753
目標均價
+15.32%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Labcorp Holdings Inc亮點

亮點風險
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
高分紅
公司屬於高分紅公司,最新股息支付率32.56%
估值低估
公司最新PE估值25.77,處於3年歷史低位
機構加倉
最新機構持股83.09M股,環比增加0.91%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉94.00股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.29

Labcorp Holdings Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Labcorp Holdings Inc簡介

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
公司代碼LH
公司Labcorp Holdings Inc
CEOSchechter (Adam H)
網址https://www.labcorp.com/

常見問題

Labcorp Holdings Inc(LH)的當前股價是多少?

Labcorp Holdings Inc(LH)的當前股價是 260.700。

Labcorp Holdings Inc 的股票代碼是什麼?

Labcorp Holdings Inc的股票代碼是LH。

Labcorp Holdings Inc股票的52週最高點是多少?

Labcorp Holdings Inc股票的52週最高點是293.720。

Labcorp Holdings Inc股票的52週最低點是多少?

Labcorp Holdings Inc股票的52週最低點是209.375。

Labcorp Holdings Inc的市值是多少?

Labcorp Holdings Inc的市值是21.64B。

Labcorp Holdings Inc的淨利潤是多少?

Labcorp Holdings Inc的淨利潤為746.00M。

現在Labcorp Holdings Inc(LH)的股票是買入、持有還是賣出?

根據分析師評級,Labcorp Holdings Inc(LH)的總體評級為買入,目標價格為299.753。

Labcorp Holdings Inc(LH)股票的每股收益(EPS TTM)是多少

Labcorp Holdings Inc(LH)股票的每股收益(EPS TTM)是10.252。
KeyAI